Clinical trial

Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.

NCT02690467

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-09-06

PhaseNA

Study timeline

Study start (actual)2016-09-06Date precision: day

Registry last updated2017-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

Insupen G34x3,5mmDEVICE

Insupen G32x4mmDEVICE

Sponsors & collaborators

Center for Outcomes Research and Clinical Epidemiology, Italylead sponsor

Artsana S.p.a.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02690467 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.